As a leading 9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid supplier, we deliver high-quality products across diverse grades to meet evolving needs, empowering global customers with safe, efficient, and compliant chemical solutions.
What is the chemical structure of 9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-[ 1,4] oxazino [2,3,4-ij] quinoline-6-carboxylic acid?
This is a question about the chemical structure, and the chemical nomenclature involved is quite complicated. I will use the ancient Chinese saying of "Tiangong Kaiwu" to analyze and answer it for you.
Looking at the "9%2C10+-+%E4%BA%8C%E6%B0%9F+-+3+-+%E7%94%B2%E5%9F%BA+-+7+-+%E6%B0%A7%E4%BB%A3+-+2%2C3+-+%E4%BA%8C%E6%B0%A2+-+7H+-+%5B1%2C4%5D%E6%81%B6%E5%97%AA%E5%B9%B6%5B2%2C3%2C4+-+ij%5D%E5%96%B9%E5%95%89+-+6+-+%E7%BE%A7%E9%85%B8" mentioned by it, after careful consideration, this may be the structural description of a complex organic compound.
According to its naming clue, the 9th and 10th positions contain diene structure, the 3rd position is connected with methyl, the 7th position is aerobic, the 2nd and 3rd positions contain dinitrogen, and there are 7 hydrogen atoms. It is also mentioned that [1,4] naphthoquinone and [2,3,4-ij] perylene are related structures, and the 6th position may have specific substituents related to carboxylic acids. In general, this compound may be a complex carboxylic acid derivative containing a fused structure of naphthoquinone and perylene, with methyl, oxo, dinitrogen and other substituents.
Such structures occasionally appear in natural products or synthetic compounds, and their unique structures endow them with specific chemical and biological activities. Or have potential application value in drug research and development, materials science and other fields. Although this description is not a standard chemical nomenclature, it can be roughly deduced from the outline of its chemical structure. I hope this answer can relieve your confusion about the chemical structure.
What are the main physical properties of 9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H - [1,4] oxazino [2,3,4-ij] quinoline-6-carboxylic acid?
9% 2C10-diene-3-methyl-7-oxide-2% 2C3-dioxide-7H-[ 1% 2C4] oxazino [2% 2C3% 2C4-ij] pyran-6-carboxylic acids have a variety of important physical properties. Due to its unique molecular structure, it has certain stability. In terms of chemical stability, due to the presence of a conjugate system in the structure, the compound has certain resistance to some common chemical reagents, is not prone to simple substitution or addition reactions, and can maintain its own structural integrity in a milder chemical environment.
In terms of physical state, under normal circumstances, the compound may exist in solid form, because of the interaction of van der Waals forces and possible hydrogen bonds between molecules, which prompts the molecules to closely arrange and form a solid lattice structure.
In terms of solubility, due to the polar carboxyl group and partial oxidation group in the molecule, as well as the relatively non-polar hydrocarbon skeleton, it may have a certain solubility in polar solvents such as ethanol and acetone, while the solubility in non-polar solvents such as n-hexane is relatively low. This solubility characteristic makes it possible to design suitable experimental protocols according to this property when separating, purifying and selecting reaction solvents.
From the perspective of optical properties, due to the existence of conjugated systems, the compound may absorb at specific wavelengths and exhibit certain optical activities, which can be used for research and applications in related fields such as optical materials. These physical properties are of great significance for in-depth understanding of the compound's behavior in chemical reactions and potential applications in materials science, drug development, and other fields.
9,10-Difluoro-3-methyl-7-oxo-2,3-dihydro-7H - [1,4] oxazino [2,3,4-ij] quinoline-6-carboxylic acid in which applications?
9% 2C10-diene-3-methyl-7-oxide-2% 2C3-dihydro-7H-[ 1% 2C4] oxazolo [2% 2C3% 2C4-ij] fluorescent-6-carboxylic acid has applications in many fields.
In the field of medicine, this compound may be developed into a drug with specific therapeutic effects due to its unique chemical structure and characteristics. For example, it may be able to demonstrate regulatory or interventional effects in response to specific physiological mechanisms or targets involved in some diseases, and may become a key component of new therapeutic drugs.
In the field of materials science, because its structure contains specific functional groups and conjugated systems, it may endow materials with unique optical, electrical or mechanical properties. Like in the field of fluorescent materials, it may be used as a core luminescent substance, applied to fluorescent labeling, display technology, etc., injecting new vitality into the development of materials science.
In the field of organic synthetic chemistry, this compound can serve as an important synthetic intermediate. Chemists use its unique structure to construct more complex and functional organic molecules through various organic reactions, promoting frontier research in organic synthetic chemistry and assisting in the creation and development of new compounds.
In conclusion, 9% 2C10-diene-3-methyl-7-oxidized-2% 2C3-dihydro-7H- [1% 2C4] oxazolo [2% 2C3% 2C4-ij] fluorescent-6-carboxylic acids have shown wide application prospects in many fields such as medicine, materials science, and organic synthetic chemistry, which is of great significance to technological innovation and development in various fields.
What are the synthesis methods of 9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H - [1,4] oxazino [2,3,4-ij] quinoline-6-carboxylic acid?
9% 2C10-diene-3-methyl-7-oxo-2% 2C3-diacid-7H- [1% 2C4] oxazolo [2% 2C3% 2C4-ij] pyridine-6-carboxylic acid The synthesis method is as follows:
A compound containing a diene structure can be used as a starting material to introduce a 3-methyl group by reacting with a methylating agent under suitable reaction conditions, such as in the presence of a specific catalyst. Next, using an oxidation reaction, the specific position is oxidized to a 7-oxo structure. After that, through carboxylation reaction, a 2% 2C3-diacid structure is constructed. Then through cyclization reaction, a heterocyclic structure of [1% 2C4] oxazolo [2% 2C3% 2C4-ij] pyridine is formed. During the reaction process, the reaction temperature, reaction time and the proportion of reactants need to be precisely controlled to ensure the smooth progress of each step of the reaction and the purity of the product. After each step of the reaction, separation and purification operations are carried out, such as column chromatography, recrystallization, etc., to remove impurities and obtain high-purity intermediate products, and finally obtain the target product 9% 2C10-diene-3-methyl-7-oxo-2% 2C3-diacid-7H - [1% 2C4] oxazolo [2% 2C3% 2C4-ij] pyridine-6-carboxylic acid.
What are the market prospects for 9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H - [1,4] oxazino [2,3,4-ij] quinoline-6-carboxylic acids?
The formula you mentioned seems to be the expression of chemical substances, but it is quite complicated and strange. In my opinion, this may be a simple description of the structure of a complex organic compound.
Looking at its "9%2C10+-+%E4%BA%8C%E6%B0%9F+-+3+-+%E7%94%B2%E5%9F%BA+-+7+-+%E6%B0%A7%E4%BB%A3+-+2%2C3+-+%E4%BA%8C%E6%B0%A2+-+7H+-+%5B1%2C4%5D%E6%81%B6%E5%97%AA%E5%B9%B6%5B2%2C3%2C4+-+ij%5D%E5%96%B9%E5%95%89+-+6+-+%E7%BE%A7%E9%85%B8", where words such as "diene", "methyl", "oxidation" and "dinitrogen" can be deduced from carbon-carbon double bonds, methyl groups, reactions or structures involving oxygen, and nitrogen-containing parts.
As for its market prospects, it needs to be viewed from many aspects. If this compound is new and has unique chemical properties and functions, such as in the field of medicine, it can be used as a potential drug intermediate. If it can show good pharmacological activity and low toxic and side effects, it may have a broad market after in-depth research and development and clinical trials. In the field of materials, if it can give materials special properties, such as high strength, high conductivity, etc.
However, market development is not easy, and it is necessary to consider R & D costs, production process difficulties, regulations and policies. If R & D costs are high, production processes are complex, and large-scale production is difficult, its marketing activities may be blocked. And regulations and policies are strict on the use and approval of new compounds, and many requirements need to be met before they can enter the market. Therefore, in general, the market prospects of this compound have both opportunities and challenges, and it needs to be further explored and practiced to be clear.